Biosimilar Monoclonal Antibody Market

The global Biosimilar Monoclonal Antibody market was valued at US$ 4639.7 million in 2022 and is projected to reach US$ 5805.5 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
Biosimilar Monoclonal Antibody Market aims to provide a comprehensive presentation of the global market for Biosimilar Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Monoclonal Antibody. Biosimilar Monoclonal Antibody Market contains market size and forecasts of Biosimilar Monoclonal Antibody in global, including the following market information:
Global Biosimilar Monoclonal Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
We surveyed the Biosimilar Monoclonal Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Limited Dilution Method
• Micromanipulation
• Soft Agar Plate Method
• Others

• Chronic & Autoimmune Diseases
• Oncology
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Biosimilar Monoclonal Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Biosimilar Monoclonal Antibody revenues share in global market, 2022 (%)

• Biocon
• Accord Healthcare
• AET Biotech
• Amgen
• Celltrion
• Reddy's Laboratories
• Hospira
• 3SBio
• Allergan
• Alvartis

Chapter 1: Introduces the definition of Biosimilar Monoclonal Antibody, market overview.
Chapter 2: Global Biosimilar Monoclonal Antibody market size in revenue.
Chapter 3: Detailed analysis of Biosimilar Monoclonal Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.